These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 4043101

  • 1. Conversion of supraventricular arrhythmias to sinus rhythm using flecainide.
    Goy JJ, Grbic M, Hurni M, Finci L, Maendly R, Duc J, Sigwart U.
    Eur Heart J; 1985 Jun; 6(6):518-24. PubMed ID: 4043101
    [Abstract] [Full Text] [Related]

  • 2. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG.
    Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395
    [Abstract] [Full Text] [Related]

  • 3. [Value of flecainide in supraventricular arrhythmias].
    Chouty F, Leclercq JF, Coumel P.
    Ann Cardiol Angeiol (Paris); 1986 Apr 25; 35(4):237-41. PubMed ID: 3740779
    [Abstract] [Full Text] [Related]

  • 4. Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias.
    Camm AJ, Hellestrand KJ, Nathan AW, Bexton RS.
    Drugs; 1985 Apr 25; 29 Suppl 4():7-13. PubMed ID: 4006783
    [Abstract] [Full Text] [Related]

  • 5. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm.
    Crozier IG, Ikram H, Kenealy M, Levy L.
    Am J Cardiol; 1987 Mar 01; 59(6):607-9. PubMed ID: 3103410
    [Abstract] [Full Text] [Related]

  • 6. The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias.
    Orning OM.
    Eur Heart J; 1984 Sep 01; 5 Suppl B():81-6. PubMed ID: 6437821
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of flecainide acetate in rapid atrial fibrillation complicating Wolff-Parkinson-White syndrome.
    Kappenberger LJ, Fromer MA, Shenasa M, Gloor HO.
    Clin Cardiol; 1985 Jun 01; 8(6):321-6. PubMed ID: 4006340
    [Abstract] [Full Text] [Related]

  • 8. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Bonnet P, Scala PJ, Demeyer JF.
    Arch Mal Coeur Vaiss; 1985 Oct 01; 78 Spec No():81-90. PubMed ID: 3938264
    [Abstract] [Full Text] [Related]

  • 9. Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm.
    Borgeat A, Goy JJ, Maendly R, Kaufmann U, Grbic M, Sigwart U.
    Am J Cardiol; 1986 Sep 01; 58(6):496-8. PubMed ID: 3529911
    [Abstract] [Full Text] [Related]

  • 10. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.
    Nathan AW, Hellestrand KJ, Bexton RS, Banim SO, Spurrell RA, Camm AJ.
    Am Heart J; 1984 Feb 01; 107(2):222-8. PubMed ID: 6695656
    [Abstract] [Full Text] [Related]

  • 11. Long term use of flecainide in patients with supraventricular tachycardia.
    Neuss H.
    Drugs; 1985 Feb 01; 29 Suppl 4():21-5. PubMed ID: 4006776
    [Abstract] [Full Text] [Related]

  • 12. The proarrhythmic effects of flecainide.
    Nathan AW, Hellestrand KJ, Bexton RS, Spurrell RA, Camm AJ.
    Drugs; 1985 Feb 01; 29 Suppl 4():45-53. PubMed ID: 4006779
    [Abstract] [Full Text] [Related]

  • 13. Use of flecainide acetate for refractory junctional tachycardias in children with the Wolff-Parkinson-White syndrome.
    Ward DE, Jones S, Shinebourne EA.
    Am J Cardiol; 1986 Apr 01; 57(10):787-90. PubMed ID: 3962866
    [Abstract] [Full Text] [Related]

  • 14. Treatment of refractory supraventricular arrhythmias with flecainide acetate.
    Till JA, Rowland E, Shinebourne EA, Ward DE.
    Arch Dis Child; 1987 Mar 01; 62(3):247-52. PubMed ID: 3105471
    [Abstract] [Full Text] [Related]

  • 15. [Flecainide and anti-arrhythmia therapy].
    Croce L, Romano S, Pozzoni L, Lomuscio A.
    Minerva Med; 1988 Mar 01; 79(3):229-34. PubMed ID: 3129677
    [Abstract] [Full Text] [Related]

  • 16. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
    Hohnloser SH, Zabel M.
    Am J Cardiol; 1992 Aug 20; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency.
    Barranco F, Sanchez M, Rodriguez J, Guerrero M.
    Intensive Care Med; 1994 Aug 20; 20(1):42-4. PubMed ID: 8163757
    [Abstract] [Full Text] [Related]

  • 18. Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis.
    van Wijk LM, Crijns HJ, van Gilst WH, Wesseling H, Lie KI.
    Am Heart J; 1989 Feb 20; 117(2):365-9. PubMed ID: 2492738
    [Abstract] [Full Text] [Related]

  • 19. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G, Balakumaran K, Lubsen J, Roelandt J, Hugenholtz PG.
    Cardiology; 1984 Feb 20; 71(1):30-9. PubMed ID: 6722846
    [Abstract] [Full Text] [Related]

  • 20. Flecainide acetate for the treatment of atrial and ventricular arrhythmias.
    Apostolakis S, Oeff M, Tebbe U, Fabritz L, Breithardt G, Kirchhof P.
    Expert Opin Pharmacother; 2013 Feb 20; 14(3):347-57. PubMed ID: 23294160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.